Dermatology · Scottsdale, AZ
Dermatology and skin studies in Scottsdale, AZ
9 recruiting studies have a site in Scottsdale.
9 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Sanofi
- Location
- Scottsdale, AZ + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Sanofi
- Location
- Scottsdale, AZ + 16 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Bristol-Myers Squibb
- Location
- Scottsdale, AZ + 90 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Pfizer
- Location
- Scottsdale, AZ + 13 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingPhase 3
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU…
Celldex Therapeutics
- Location
- Scottsdale, AZ + 24 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company
- Location
- Scottsdale, AZ + 28 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 1/Phase 2
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Sanofi Pasteur, a Sanofi Company
- Location
- Scottsdale, AZ + 78 other US sites
- Eligibility basics
- Ages 18–45
- RecruitingPhase 2
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Navigator Medicines, Inc.
- Location
- Scottsdale, AZ + 13 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Scottsdale, AZ + 53 other US sites
- Eligibility basics
- Ages 12–17
Who these studies look for
Most require an active, diagnosed skin condition of a certain severity and a pause on some current treatments before starting.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.